Scientists have identified a number of genes in lung cancer cells which, when downregulated, make the cancer cells especially vulnerable to a type of chemotherapy.
The study, reported in April 12, 2007 issue of Nature (Vol. 446, No. 7137, pp. 815-819), highlights a new way to screen for alterations in cancer cells that make them specifically sensitive to therapeutics, so that treatment may leave normal tissue relatively unharmed.
Michael A. White and colleagues used a genome-wide RNA interference screen to identify 87 genes that are involved in the response of cancer cells to paclitaxel. Reducing the expression of a number of these genes sensitizes lung cancer cells to paclitaxel at concentrations 1,000-fold lower than otherwise needed for a significant response. Some of the identified genes are already targets of currently available compounds and could be tested for responses to combinations of drugs, whereas others could be new therapeutic targets.
Michael A. White (University of Texas Southwestern Medical Center, Dallas, TX, USA)
(C) Nature press release.
Message posted by: Trevor M. D'Souza
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking